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An auxetic conductive cardiac patch (AuxCP) for the treatment of myocardial 
infarction (MI) is introduced. The auxetic design gives the patch a negative 
Poisson’s ratio, providing it with the ability to conform to the demanding 
mechanics of the heart. The conductivity allows the patch to interface with 
electroresponsive tissues such as the heart. Excimer laser microablation is 
used to micropattern a re-entrant honeycomb (bow-tie) design into a chitosan-
polyaniline composite. It is shown that the bow-tie design can produce 
patches with a wide range in mechanical strength and anisotropy, which can 
be tuned to match native heart tissue. Further, the auxetic patches are conduc-
tive and cytocompatible with murine neonatal cardiomyocytes in vitro. Ex vivo 
studies demonstrate that the auxetic patches have no detrimental effect on 
the electrophysiology of both healthy and MI rat hearts and conform better 
to native heart movements than unpatterned patches of the same material. 
Finally, the AuxCP applied in a rat MI model results in no detrimental effect on 
cardiac function and negligible fibrotic response after two weeks in vivo. This 
approach represents a versatile and robust platform for cardiac biomaterial 
design and could therefore lead to a promising treatment for MI.
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represent exciting possible solutions.[2–8] 
Herein, we investigate a new biomaterial 
design for cardiac patches to treat myo­
cardial infarction (MI), one of the largest 
contributors to CVDs. MI are caused by 
an occlusion of one or more of the coro­
nary arteries, resulting in the myocardial 
tissue becoming ischemic and reducing the 
heart’s ability to pump blood around the 
body.[9] Cardiac patches seek to strengthen 
the tissue, supply cells or growth factors to 
vitalize the tissue, and bridge electrical and/
or mechanical stimulation across the infarct 
to maintain and improve cardiac function. 
For a cardiac patch to be successful in trig­
gering regeneration of the myocardium, the 
biomaterial design will benefit from consid­
ering and optimizing the cytocompatibility, 
electrical conductivity, and mechanical 
properties.[2–8]
It is widely accepted that the mecha­
nical properties of biomaterials used for 
treating MI are extremely important.[2–8,10] 
Typically, it is believed that the mechanical properties of a car­
diac patch should match those of healthy native heart tissue. 
However, the Young’s modulus of the native human heart 
varies from 0.02 to 0.50 MPa depending on whether the heart 
Auxetic Cardiac Patches
1. Introduction
Cardiovascular diseases (CVDs) are the leading causes of death 
and disability worldwide.[1] Biomaterials and regenerative therapies 
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is in systole or diastole, with infarct tissue being even stiffer.[7,8] 
This range is broad and the optimum mechanical properties for 
such an application are debatable.[7,8] Further research into the 
regeneration of infarcted cardiac tissue using cardiac patches 
with controllable mechanical properties will be instrumental in 
the development of future strategies for treating MI.[7,8]
Another important mechanical property which is often over­
looked is the Poisson’s ratio. The Poisson’s ratio (ν) describes 
the effect on transversal strain (εT) when a material is under 
longitudinal tension or compression, creating longitudinal 
strain (εL), and is defined by Equation (1)
T
L
ν
ε
ε
= −  (1)
Most materials typically have a positive Poisson’s ratio and as 
a result, when stretched longitudinally, they contract transver­
sally. However, auxetic materials are defined as having a nega­
tive Poisson’s ratio and therefore expand in multiple directions 
simultaneously. This results in the improvement of other unique 
properties, such as shear resistance, indentation resistance, and 
synclastic curvature, all of which are interesting properties in a 
cardiac patch.[11–13] Auxetic micropatterning is presented here 
as a unique way of incorporating these properties into cardiac 
patches. There has been very little investigation into the use of 
auxetic materials or the importance of the Poisson’s ratio in the 
field of biomaterials, particularly for treating MI.[14–17]
In addition to mechanical strength, electrical signals are vital 
to the heart’s contractions and function. Due to their inherent 
electroactive nature, conductive materials are of interest in bio­
material design for electroresponsive tissues such as the heart 
and the central nervous system. Doped­conjugated polymers 
could be particularly useful in cardiac patches due to their poten­
tial ability to improve the electrical pathway which is damaged 
in the infarct tissue after an MI.[18–23] Electroactive biomaterials 
were recently shown to favorably influence the electrophysiology 
of infarcted animal cardiac tissue ex vivo[24] and in vivo.[19] In 
contrast, the existing insulating biomaterials have been shown to 
further hinder signal propagation through the infarct tissue.[25]
Previously, our group developed a conductive cardiac patch 
with exceptional electrical stability, which was shown to increase 
the conduction velocity (CV) across the damaged electrical 
pathway of the infarct region in a rat MI model.[24] However, the 
Young’s modulus of this biomaterial is significantly greater (6.73 ± 
1.1 MPa)[24] than that reported for native human heart tissues 
(0.02–0.50 MPa).[7,8] Building on our previous work,[24] here we 
incorporate mechanical and topological anisotropy in an auxetic 
design to develop a conductive cardiac patch that can better comply 
mechanically with the heart. We introduce the ability to control and 
tune the effective stiffness and anisotropy of auxetic, conductive 
cardiac patches and we investigate their impact on cardiac function.
2. Results and Discussion
2.1. Design and Fabrication of Auxetic Cardiac Patches
There are many ways in which auxetic behavior can be 
imparted into a material.[13] The design used here is known as 
the re­entrant honeycomb or “bow­tie” deformation mechanism 
(Figure 1A).[13,26] A particularly interesting feature of this bow­
tie geometry is that it is anisotropic, that is, it is stiffer in one 
direction than the other, which is similar to native heart tissue. 
The anisotropic ratio of effective stiffness of native hearts 
has been reported over a wide range of values (1.9–3.9),[27–30] 
depending on species, age, and health. However, it is consist­
ently reported that the heart is stiffer in the circumferential 
(transverse) direction than in the longitudinal direction.[27–30] It 
is assumed that cardiac biomaterials should match native aniso­
tropic mechanical properties to not impede heart function.[27–30]
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Figure 1. A) Schematic of the bow-tie dimensions. B) Schematic illustra-
tion of the alignment of the auxetic cardiac patch (AuxCP) on the heart. 
C) Schematic illustration of the auxetic behavior of the re-entrant honey-
comb (bow-tie) geometry. D) Digital optical microscope images of the 
AuxCPs during tensile testing at 0.8% strain and 12.6% strain (scale 
bars: 1 mm).
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In this study, the stiffer direction (1­direction) of the aux­
etic cardiac patch (AuxCP) is aligned with the stiffer circum­
ferential (transverse) direction of the heart, while the less stiff 
AuxCP direction (2­direction) is aligned with the less stiff lon­
gitudinal direction of the heart (Figure 1B). When this bow­tie 
pattern is stretched in one direction, the diagonal ribs flex and 
open causing expansion in the other direction, resulting in a 
negative Poisson’s ratio (Figure 1C,D). The Poisson’s ratio is 
negative within the first 5–15% strain (depending on original 
bow­tie dimensions), a representative example is illustrated in 
Figure S1 (Supporting Information).
The material used is a conductive composite previously 
developed by our group.[24] Briefly, this composite consists of 
an interconnected network of polyaniline and phytic acid grown 
on a chitosan surface. Ammonium persulfate is used to trigger 
the polymerization of the aniline in situ, while the phytic acid 
cross­links both the chitosan and polyaniline. The phytic acid 
also has a second role as the dopant, resulting in a highly stable, 
electrically conductive thin film with the rich dark green color 
associated to the emeraldine acid oxidation state of polyaniline.
The fabrication of the bow­tie geometry was achieved 
through excimer laser microablation in the chitosan films. The 
process can be easily modified to create patches with varying 
bow­tie geometries and sizes (Figure 1A). After micropat­
terning the chitosan, the patches are coated with polyaniline 
and their precision is maintained to within 5% of the orig­
inal microablated pattern dimensions (Figure S2, Supporting 
Information). Unlike other micropatterning methods such as 
photolithography, this technique is not limited to photocurable 
materials,[7] opening the door to the micropatterning of a wide 
array of biomaterials, particularly conductive biomaterials. In 
addition, the fabrication process was optimized to produce 
40 samples (6 × 6 bow­tie repeat units) in under an hour while 
maintaining the precision of the patterning, producing cardiac 
patches considerably faster than can be achieved with many 
other rapid prototyping methods, such as common 3D printing 
techniques.[17] Therefore, this technique has great potential 
for mass production and distribution. Moreover, this is an 
extremely robust and versatile technique for 2D microfabrica­
tion of biomaterials that allows tissue specific tailoring.
2.2. Characterization of Tunable Mechanical Properties
Theoretical models based on the 2D bow­tie pattern, previ­
ously established in the literature,[26] were used to predict the 
mechanical properties of the micropatterned patches. The 
equations use the Young’s modulus of the bulk material and 
the various bow­tie dimensions (Figure 1A) to calculate the 
resultant effective stiffness (E) values and the anisotropic ratio 
of effective stiffness (E1/E2).
Tensile tests proved that varying the bow­tie dimensions 
A, B, θ, and R, can tune E1, E2, and E1/E2 as predicted by the 
theoretical model[26] (Figure 2A–H). A full table of information 
about all nine different sample sets can be found in Table S1 
(Supporting Information), including all bow­tie dimensions 
and measured mechanical properties. (Representative stress–
strain curves produced from these tensile tests are also shown 
in Figure S3, Supporting Information.)
Specifically, by increasing the length of dimension A 
from 320 to 480 µm, E1/E2 decreases from 5.71 to 1.99 
(Figure 2A,B). By increasing the length of dimension B from 
240 to 360 µm, E1/E2 increases from 1.79 to 5.11 (Figure 2C,D). 
By increasing angle θ from 40° to 80°, E1/E2 increases from 
0.85 to 3.48 (Figure 2E,F). Hence, by varying any of these three 
dimensions, we can tune the cardiac patch to have an aniso­
tropic ratio of effective stiffness matching the reported ratio for 
native heart tissue (rat heart Etrans/Elong: 1.9 to 3.9).[27–30] This 
technique provides greater flexibility and control over a wide 
range of anisotropic mechanical properties, allowing the mate­
rial to be tailored to match patient needs with varying ages 
or health conditions. This is in contrast to Engelmayr et al. 
who achieved a fixed anisotropy of effective stiffness of 2.7 
with their nonconductive, nonauxetic micropattered cardiac 
patch.[29]
Varying R has little effect on E1/E2 (Figure 2G,H). How­
ever, when decreasing R from 150 to 50 µm, the magnitudes 
of E1 and E2 decrease from 2.77 ± 0.5 to 0.39 ± 0.2 MPa and 
from 1.10 ± 0.1 to 0.14 ± 0.04 MPa, respectively, providing an 
additional level of control in mechanical properties. As well as 
matching the anisotropic ratio of effective stiffness, this method 
allows us to match the effective stiffness of the cardiac patch to 
native human heart tissue (0.02–0.50 MPa).[7,8]
Ultimate tensile strength (UTS) and strain at failure are 
in the range of 0.06 ± 0.03 to 1.53 ± 0.9 MPa and 27 ± 6 to 
96 ± 29%, respectively, which are comparable to reported values 
for native human heart tissue.[7,31] Poisson’s ratio values were 
negative for all but one of the sets of bow­tie dimensions. The 
exception was for the patch with an angle between the ribs of 
80°, which leaves little room for it to expand laterally when 
stretched (Poisson’s ratio of ν12: 0.00 ± 0.00 and ν21: 0.08 ± 0.1). 
The majority of the patches were found to have Poisson’s ratios 
in the range of −1.45 ± 0.2 to −0.15 ± 0.1 (Table S1, Supporting 
Information). The Poisson’s ratio can also be tuned to a desired 
value by tuning the bow­tie dimensions, as has been demon­
strated before with a nonconductive poly(ethylene glycol) mate­
rial by Zhang et al.[15] They developed a biomaterial patterned 
with the same re­entrant honeycomb geometry with a tuned 
Poisson’s ratio for the purpose of probing how cells sense and 
respond to these local subtle differences in mechanical prop­
erties.[15] However, their two­photon fabrication technique is 
restricted to photocurable materials, whereas the excimer laser 
microablation fabrication techniques used here can be used for 
almost any biomaterial.
As a result of the wide range of effective stiffness (human 
heart: 0.02–0.50 MPa)[7,8] and anisotropy (rat heart: 1.9–3.9),[27–30] 
reported for native healthy heart tissues, the ideal mechan­
ical properties for a cardiac patch are still under debate. Our 
new approach provides a promising technique to probe the 
appropriate biomaterial mechanical properties for treating 
infarcted hearts. The biomaterials can be tuned to a wide 
range of desired values of effective stiffness and anisotropy 
while maintaining the bulk properties. Moreover, this control 
over the mechanical properties is particularly exciting as it 
can be extended to other tissues and applications where the 
tissues are expanded under stress, such as arterial stents,[32]  
esophageal stents,[14] and osteochondral implants[33,34] among 
others.
1800618 (3 of 12) © 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2018, 1800618
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Figure 2. A,C,E,G) Individual effective stiffness (E1 and E2) compared with theoretical predictions, for changing bow-tie dimensions A, B, θ, and R, 
respectively. B,D,F,H) Anisotropic ratio of effective stiffness (E1/E2) compared to theoretical predictions and native rat hearts, for changing bow-
tie dimensions A, B, θ, and R, respectively. (Theoretical predictions were calculated from ref. [26]. Adult rat heart tissue values were taken from 
refs. [27–30]). (N = 10, *p < 0.05, **p < 0.001; Mean ± SD).
www.afm-journal.dewww.advancedsciencenews.com
2.3. Characterization of Conductivity
The AuxCPs maintain a similar level of conductivity compared 
to the unpatterned cardiac patches (UnpatCPs) previously pro­
duced,[24] with values in the 10−2 S cm−1 range (UnpatCP: 13.6 ± 
2.9 × 10−2 S cm−1, AuxCP 1­dir: 9.3 ± 1.5 × 10−2 S cm−1 and 
AuxCP 2­dir: 2.4 ± 0.9 × 10−2 S cm−1; Figure 3). Interestingly, 
the conductivity of the AuxCP is also anisotropic. The data 
show that conductivity is significantly higher in the 1­direc­
tion than the 2­direction. Similarly, the results also show that 
the UnpatCP has a significantly higher conductivity than the 
AuxCP in the 2­direction. The stated conductivity values are cal­
culated by taking the length between the two electrodes as the 
current travel distance. While this is true for the UnpatCP, it is 
more complex for the AuxCP. By following the pattern in each 
direction, it can be seen that the distance the current travels is 
longer than the distance between the two electrodes, with the 
longest route being in the 2­direction. The inverse of these 
calculated effective distances correlates well with the trend 
in conductivities, as can be seen in Figure 3. Overall the pat­
terning has a significant yet small effect on the conductivity of 
the patches, as they maintain conductivities in the 10−2 S cm−1 
range.
The conductivity values measured for the AuxCPs are 
comparable with other polyaniline­based composites used 
for cardiac tissue engineering from literature. For example, 
the polyaniline­poly(glycerol sebacate) composite produced 
by Qazi et al.[35] has conductivities in the 10−3 S cm−1 range 
with 15 v/v% polyaniline and in the 10−2 S cm−1 range with 
30 v/v% polyaniline.[35] However, we previously reported that 
our chitosan­polyaniline composite has superior electrical sta­
bility over other such polyaniline­based composites,[24] a vital 
characteristic for tissue engineering applications. Moreover, 
the electrical conductivities reported here for the AuxCPs fall 
within the range believed to be relevant for tissue engineering 
applications (10−4–10 S cm−1).[20] However, the ideal electrical 
conductivity for cardiac biomaterials is still undefined and is an 
area that would benefit from further investigation.
2.4. Neonatal Rat Ventricular Myocytes Cultured on Auxetic 
Cardiac Patches
In vitro cell culture experiments were carried out to demonstrate 
the cytocompatibility of the patches, prior to ex vivo and in vivo 
experimentation. Both neonatal rat ventricular myocytes (NRVM) 
and fibroblasts were cultured on AuxCPs for 3 d (Figure S4A,B, 
Supporting Information). The cells were well dispersed along the 
pattern and presented the elongated phenotype expected of car­
diomyocytes. Moreover, the apparent striation pattern, positive 
for α­actinin, confirms cardiomyocyte phenotype (Figure S4B, 
Supporting Information). Some NRVMs can be seen to take on a 
more circular morphology and form aggregates, suggesting dead 
cells. However, a cell proliferation assay (see the Experimental 
Section, Supporting Information, for a description) demon­
strates that cells on both the AuxCPs and UnpatCPs have sig­
nificantly higher levels of cell metabolic activity compared to the 
glass control (Figure S4C, Supporting Information). Hence, both 
the AuxCPs and UnpatCPs can be considered cytocompatible for 
both cardiac fibroblasts and cardiomyocytes.
2.5. Ex Vivo Investigation of Cardiac Electrophysiology
After optimizing the auxetic mechanical properties, character­
izing the conductivity and demonstrating the cytocompatibility of 
these cardiac patches, we investigated the impact of the patches 
on the electrophysiological and mechanical function of the 
heart. First, to probe the effect of the AuxCPs electrical conduc­
tion, we carried out ex vivo experiments on both ultrathin myo­
cardial slices and whole rat hearts[24] using AuxCP­1 (Table S1, 
Supporting Information; setup number 1). The results sug­
gested that AuxCP­1 had an anisotropy in conductivity between 
directions 1 and 2 (Figure 3) and was therefore an interesting 
candidate for investigating the impact of its electrical conduc­
tivity when attached to the heart tissue in two possible orien­
tations (1­dir: where the more conductive 1­direction of the 
AuxCP is positioned parallel to the longitudinal axis of the car­
diac tissue; 2­dir: where the more conductive 1­direction of the 
AuxCP is positioned perpendicular to the longitudinal axis of 
the cardiac tissue).
2.5.1. Impact of Auxetic Cardiac Patches on Myocardial Slices
Upon electrical field stimulation, we observed a reduction in 
contractility when placing the AuxCPs on myocardial slices, 
1800618 (5 of 12) © 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2018, 1800618
Figure 3. A,B) Schematic of the route the current travels along the patch 
in the 1- and 2-directions, respectively. C) Two-point probe conductivity 
measurements for the unpatterned cardiac patches (UnpatCPs) and the 
auxetic cardiac patches (AuxCPs) in both the 1- and 2-directions, corre-
lated with the inverse effective distance that the current travels along the 
patch (N = 3–5, *p < 0.05; Mean ± SD).
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compared to the slices on their own. This is reported as the 
relative contractility, that is, 100% without a patch to; Slice + 
1­dir AuxCP: 82.6 ± 5.0% and Slice + 2­dir AuxCP: 86.0 ± 4.1%; 
Figure 4Ai. However, we did not observe a significant differ­
ence between the two possible AuxCP orientations. In both 
cases, we observed a reduced contractility of the slices. We 
hypothesize that this effect is due to the electrical conductivity 
of the AuxCP. To this end, we conducted the same experiment 
with nonconductive chitosan patches, consisting of the same 
auxetic micropattern yet without the polyaniline coating. Con­
tractility upon electrical stimulation of the myocardial slices 
with this chitosan patch was comparable to slices without 
any patch. This suggests that the presence of the doped­pol­
yaniline is critical to the observed reduction in contractility, 
which could be attributed to the electroactive nature of the pol­
yaniline­chitosan composite patch compared to the chitosan­ 
only patch.
This is comparable with our previous work, which found that 
the UnpatCPs reduced the contractility of the slices while the 
chitosan­only patches of the same architecture did not influ­
ence the contractility of the slices.[24] Interestingly, however, 
this previous work also showed a size­dependent effect, with 
the larger (25 mm2) UnpatCPs having the greatest effect on 
contractility compared to the smaller patches (17 and 9 mm2), 
where no reduction in contractility was observed.[24]
In the experiments reported here, we used AuxCPs of sim­
ilar dimensions (21.1 mm2). Taking the patterning into con­
sideration, the total surface area of the AuxCPs, and there­
fore the material placed on the myocardial slices, is consid­
erably less (10.0 mm2). Contrary to our expectations and our 
previous work, this reduced surface area still affected the 
contractility of the myocardial slices. We thus propose that 
the contractility of myocardial slices upon electrical stimu­
lation is influenced not only by the size, weight, and con­
ductivity of a patch, but also by its geometry and auxetic 
properties. The ex vivo evaluations described here further 
underpin the importance of considering various aspects in 
cardiac patch design, and highlight the complexity in trying 
to elucidate the role of these different parameters from one 
another experimentally. To gain further insight into the true 
effect of the AuxCPs on cardiac function, further ex vivo, as 
well as in vivo experiments have been conducted and their 
descriptions follow.
A microelectrode array (MEA) system[24] was also used to 
examine the AuxCPs on the myocardial slices, which measures 
signal propagation through the tissue upon electrical field stim­
ulation, allowing activation time maps to be produced along 
with the corresponding calculated peripheral CVs (Figure 4Aii). 
Because CV is faster along the fibers,[24] the slice is stimu­
lated in two orientations, longitudinal in­line with the fibers 
and transverse across the fibers. The peripheral CVs for both 
slice orientations (longitudinal and transverse) are unaffected 
by the addition of the AuxCPs in either direction (1­ or 2­direc­
tion) and there is no significant difference seen for the chitosan 
patches (Figure 4Aii).
Previously, we have reported a reduced CV for the myocar­
dial slices with UnpatCPs both in the transversal and longi­
tudinal directions on the MEA system.[24] Here, we show that 
the AuxCPs do not restrict the CV neither in the transversal 
nor in the longitudinal directions on the MEA system, which 
could be due to the significantly smaller surface area of the 
AuxCPs (10 mm2) compared to the UnpatCPs (25 mm2). How­
ever, this would contradict the results seen for the force trans­
ducer contractility measurements. The MEA system stimu­
lates and reads the response specifically from the bottom side 
of the tissue while the patch is placed on the top side of the 
tissue. This is different from the force transducer contractility 
measurements, which measures an overall effect on the tissue. 
Hence, it is also possible that the effect of the AuxCPs on CV 
is restricted to the surface of the tissue and does not pass all 
the way through the tissue (≈15 cell layers) to the MEA dish 
electrodes.
2.5.2. Impact of Auxetic Cardiac Patches on Whole Hearts
Optical mapping experiments[24] were conducted to investigate 
the effect of the AuxCPs on the electrophysiology of whole 
hearts. The optical mapping measurements were taken before 
and after application of the AuxCPs. The optical measurements 
were processed to produce activation time maps and conduc­
tion velocity maps (Figure 4B). As expected, prior to applica­
tion of the patches, the CV is significantly reduced in the MI 
hearts compared to the healthy hearts (Figure 4Ci). Similar to 
the heart slice measurements, the patch was placed in two dif­
ferent orientations. The orientation of the patch had an impact 
on the CV for healthy hearts. The patch oriented in the 1­direc­
tion significantly reduced the CV (from 100% without a patch 
to 82.9 ± 5.5, 84.9 ± 7.7, and 87.5 ± 8.9% for the local basal, 
local apical, and base to apex measurements, respectively). The 
patch oriented in the 2­direction had no significant impact on 
the CV of healthy hearts (Figure 4Cii). In contrast, with MI 
hearts neither orientation of the patch had a significant impact 
on CV (Figure 4Ciii).
The results for the UnpatCPs and nonconductive unpat­
terned chitosan patches were published previously[24] and so for 
animal welfare reasons these experiments were not repeated. 
We previously showed a significant decrease in CV in healthy 
hearts and a significant increase in CV in MI hearts when the 
UnpatCPs were applied, and no significant difference in either 
case for the chitosan patches.[24] This whole heart CV data 
combined with the myocardial slice CV data suggests that the 
UnpatCPs could influence the electrophysiological signaling 
of the heart.[24] In this study, we show that the AuxCPs do not 
induce a significant difference in CV for both healthy and MI 
whole hearts and healthy slices, when oriented in the correct 
direction (2­dir: less stiff patch direction aligned with less stiff 
longitudinal direction of the heart). Furthermore, an additional 
AuxCP (AuxCP­10) was designed with a new set of bow­tie 
dimensions to maximize surface area (AuxCP­10 = 18.7 mm2, 
AuxCP­1 = 10.0 mm2), and this design did not influence the 
CV of either healthy or MI hearts in both 1­ and 2­directions 
(Table S2 and Figure S5, Supporting Information). Therefore, 
this demonstrates that the AuxCPs do not have a detrimental 
effect on the electrophysiology of both healthy and infarcted 
hearts over a wide range of dimensions and surface areas.
Nevertheless, these preclinical experiments cannot fully 
predict the effect of AuxCPs on human heart electrophysiology 
Adv. Funct. Mater. 2018, 1800618
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Figure 4. Ai) Contractility of the myocardial slices in response to field stimulation (N = 12–16, *p < 0.05; Mean ± SE). Aii) Peripheral conduction 
velocity (CV) of the slices measured by an MEA system, including CV maps (N ≥ 6, *p < 0.05; Mean ± SE). B,C) Ex vivo whole heart optical mapping 
measurements. B) Photos (scale bar: 2 mm), representative activation time maps and CV maps before and after auxetic cardiac patch (AuxCP) appli-
cation (1-dir), on Bi) healthy hearts and Bii) hearts two weeks after induced myocardial infarction (MI; permanent ligation of left anterior descending 
coronary artery). Ci) CV in healthy and MI hearts (N ≥ 10, *p < 0.05; Mean ± SE). CV in Cii) healthy hearts and Ciii) MI hearts after patch application, 
normalized to the hearts without the patch (N ≥ 5, *p < 0.05; Mean ± SE).
www.afm-journal.dewww.advancedsciencenews.com
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and function. As auxetic behavior is independent of scale, 
larger AuxCPs will maintain similar mechanical properties. 
In addition, the excimer laser microablation process lends 
itself well to scale­up; with the ability for high­throughput 
production; and patch size only limited by the XY stage 
dimensions (currently ≈150 × 150 mm) and thus theoreti­
cally suitable for up to human heart dimensions. However, 
left ventricular wall thickness and heart rate are significantly 
different between rats and humans, and the effects of patch 
application in larger animals and human heart samples 
require further investigation to inform future clinical applica­
tions of this technology.
The increase in CV previously observed when the UnpatCPs 
were applied to MI hearts is an interesting and promising 
result.[24] Despite the observed reduction in CV for ex­vivo 
healthy hearts upon application of the UnpatCPs, in vivo 
implantation of the patch in healthy hearts showed that it 
did not influence the proarrhythmic state of the heart under 
stress. Nonetheless, from both studies it appears that an ideal 
case would be to tune the conductive properties of the car­
diac patches so that they increase the CV in the infarct area 
closer to the values expected of healthy heart tissue. This could 
conceivably be achieved with a deeper understanding of how 
to manipulate cardiac electrophysiology, along with further 
optimization of pattern dimensions and the material’s conduc­
tive properties. Currently, the details of the molecular mecha­
nism by which doped­conjugated polymer based materials 
affect cardiac  electrophysiology are not fully  understood and 
this is an interesting question worth further investigation in 
future studies.
2.6. Ex Vivo Investigation of Mechanical Integration
The main purpose of micropatterning the cardiac patch was 
to improve its mechanical conformability to native heart 
tissue. In order to investigate and quantify this, a bespoke, 
custom­made device was built, in which dissected sections 
of the left ventricle could be placed into grips, and cyclically 
stretched at specific distances and frequencies (Figure 5A). For 
these experiments AuxCP­2 was used (Table S1, Supporting 
Information; setup number 2), as this has an anisotropy 
of E1/E2 = 2.79, which falls in the middle of the mechanical 
anisotropy range previously reported for native heart tissue 
(rat heart Etrans/Elong: 1.9 to 3.9).[27–30] The patches were always 
oriented to match the mechanical anisotropy of the patch to 
the tissue (i.e., the less stiff direction of the patch (2­direction) 
parallel to the less stiff longitudinal axis of the heart tissue). 
Adv. Funct. Mater. 2018, 1800618
Figure 5. Ex vivo mechanical testing demonstrates that auxetic patches stretch and conform to the native tissue movements while providing mechan-
ical support. A) Biomechanical rig setup with inset showing a digital optical microscope image annotated to illustrate the tissue and patch areas and 
the longitudinal (Long) and transverse (Tran) directions, (scale bar: 5 mm). B) Strain across the whole surrounding rat left ventricle tissue area and 
C) strain across the patch area for attached unpatterned (UnpatCP) or auxetic cardiac patches (AuxCP), and normalized to strain of tissue without 
patches. Normalized strains reported for transverse direction, longitudinal direction, and strain ratio (Tran/long) (N = 5, *p < 0.05; Mean ± SE).
www.afm-journal.dewww.advancedsciencenews.com
The patches were attached to the tissue by the previously 
described laser photoadhesion technique.[24]
Longitudinal strains, transverse strains, and the ratio of the 
two strains were measured from digital microscope videos of 
the tissue as it was stretched with either an AuxCP or UnpatCP 
attached, and normalized to the tissue before the patch was 
attached (Figure 5B,C). When analyzing strains across the 
entire tissue (≈12 × 12 mm initial tissue size) there was no sig­
nificant difference in the transverse and longitudinal strains for 
both AuxCPs and UnpatCPs compared to the tissue without a 
patch (Figure 5B), suggesting that patches do not interfere with 
global tissue mechanics.
However, strain measurements across the patch area 
(≈6 × 6 mm initial patch size) demonstrated significant 
decreases in both longitudinal and transverse strains for 
UnpatCPs compared to both the tissue without a patch and 
with AuxCPs. Further, UnpatCPs had a normalized ratio 
of strains of −0.70 ± 0.6 (Tran/Long), demonstrating a dra­
matic reversal in mechanics. We observed a greater conform­
ability of the AuxCPs to native tissue movement compared 
to the UnpatCPs. The AuxCPs significantly decreased strains 
across the patch area compared to the tissue without a patch. 
However, interestingly, although strains were reduced with 
the AuxCPs, they maintained a similar normalized ratio of 
strains as tissue without a patch (1.20 ± 0.3 and 1 ± 0, respec­
tively), suggesting that AuxCPs stretch and conform to the 
native tissue movements while providing mechanical support 
(Figure 5C).
2.7. In Vivo Investigation of Cardiac Function  
after Myocardial Infarction
We used a rat MI model to investigate the effect of the AuxCPs 
on cardiac function. Once again, we used AuxCP­2 oriented 
to match the mechanical anisotropy of the patch to the hearts 
anisotropy (Figure 1B). The AuxCP was attached to the heart 
by the previously described laser photoadhesion technique,[24] 
immediately after induction of MI through permanent liga­
tion of the left anterior descending coronary artery (LAD) (MI 
AuxCP, N = 6). We used this model as an initial proof of prin­
ciple study, although a more clinically relevant scenario would 
be to apply the patch after the MI has resolved and scar has 
formed. For animal welfare reasons a second thoracotomy, 
which would be required for such experiments, was avoided 
at this stage. However, a more clinically relevant chronic heart 
failure model will be important in future experiments. While 
some progress has been made in this field to develop a less 
invasive surgical technique for the application of a cardiac 
patch to the heart after an MI,[28] currently this would still 
require a second thoracotomy, which is highly challenging 
in rodents.
The AuxCPs remained intact and attached to the hearts two 
weeks after the surgeries (Figure 6A). A control group also 
underwent the same surgery, with an induced MI and appli­
cation of the laser, but without an AuxCP applied (MI control, 
N = 4). In addition, a healthy control group underwent the same 
surgery, with the application of the laser, but without inducing 
an MI and without applying the AuxCP (sham, N = 6).
Histological analysis shows no significant difference between 
the MI controls and the MI AuxCP hearts, suggesting negligible 
fibrotic response to the cardiac biomaterial two weeks after the 
surgeries (Figure 6B,C).
Cardiac structure and function was assessed in vivo at 1 and 
14 d after the surgery using ultrasound. The MI control and MI 
AuxCP groups showed reduced cardiac function compared to 
the healthy sham controls as expected. Both MI groups show 
similar cardiac function at 1 and 14 d after the surgeries for 
fractional shortening, left ventricular (LV) volume at end­dias­
tole, LV volume at end­systole and mitral valve (MV) E/A peak 
ratio, suggesting that the AuxCPs have no detrimental effect on 
cardiac function (Figure 6D–G). However, by ultrasound meas­
urements we also show that while the LV mass is similar for 
all groups at 1 day, by 14 d a significant increase in LV mass 
is seen for the MI control group which is not seen for the MI 
AuxCP group. A possible explanation may be that the patch 
reduces wall stress and attenuates hypertrophy (Figure 6H), as 
has been shown previously with other cardiac patches.[36] How­
ever, further evaluation of cardiomyocyte size and gene expres­
sion would be required to elucidate the role of the AuxCPs in 
attenuating hypertrophy. Greater benefit to cardiac function 
may have been observed over a longer follow­up period or 
under a chronic heart failure model, giving more time for LV 
remodeling to occur, which will be important considerations in 
future in vivo experiments for these AuxCPs.
Nevertheless, these results suggest that the AuxCPs integrate 
well with native heart tissue in vivo and have no detrimental 
effect on cardiac function, nor do they induce a significant 
fibrotic response. This approach to biomaterial design creates 
an ideal platform for future incorporation of therapeutic mol­
ecules for delivery to the epicardium.
3. Conclusion
We can create auxetic micropatterned cardiac patches by 
excimer laser microablation with mechanical properties tuned 
to match those of native heart tissue while maintaining the 
bulk properties of the material. We showed that the AuxCPs 
are conductive (≈10−2 S cm−1) and cytocompatible with cardio­
myocytes. Ex vivo experiments demonstrated that the AuxCPs 
have no detrimental effect on the cardiac electrophysiology 
of both healthy and MI hearts. Further new ex vivo experi­
ments showed that the AuxCPs stretch and conform to match 
the movements of native heart tissue, unlike the UnpatCPs. 
Finally, the AuxCPs integrated with native heart tissue without 
detrimental effect on cardiac function in a rat MI model over 
two weeks in vivo.
This study demonstrates a conductive cardiac patch 
improved through the use of an auxetic design, which can be 
tuned to match the mechanical demands of the heart and is 
a promising cardiac patch. Further, there are still many unan­
swered questions in the cardiac field as to the appropriate 
mechanics and conductivity of patches and our auxetic patch 
design is a promising tool for investigating optimal properties 
due to its high degree of tunability. Hence, the findings pre­
sented here may lead to improved biomaterial designs toward 
treating myocardial infarction.
1800618 (9 of 12) © 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2018, 1800618
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4. Experimental Section
Extended experimental descriptions can be found in the Supporting 
Information.
All chemical reagents were purchased from Sigma Aldrich (UK) or 
VWR (UK) unless specifically noted.
All animal procedures were carried out in accordance with the UK 
Home Office Animals (Scientific Procedures) Act 1986 and Directive 
2010/63/EU of the European Parliament on the protection of animals 
used for scientific purposes.
Fabrication of Auxetic Cardiac Patches—Fabrication and Physical 
Characterization of Chitosan-Polyaniline Films: The chitosan-polyaniline 
films were fabricated by the method previously described by Mawad 
et al.[24] For the AuxCPs, chitosan films were micropatterned with a 
re-entrant honeycomb (bow-tie) pattern, before coating with polyaniline 
and phytic acid.
Fabrication of Auxetic Cardiac Patches—Micropatterning by Excimer 
Laser Microablation: Chitosan films on glass slides were placed on the 
XYZ stage (accuracy ± 1 µm) of a custom-built excimer laser processing 
system with an LPX305i Excimer Laser (Lambda-Physik) charged with 
Figure 6. A) Representative images of the auxetic cardiac patch (AuxCP) attached via laser photoadhesion to the rat left ventricle during surgery, 
following a myocardial infarction (MI; permanent ligation of left anterior descending coronary artery) and a representative image of the AuxCP still 
attached and intact two weeks after surgery (MI AuxCP; scale bar: 4 mm). Representative histological cross-sections of an MI control and an MI AuxCP 
two weeks after surgery, stained with B) PicroSirius red and C) hematoxylin and eosin (H&E), arrows indicate the location of the AuxCP (scale bar: 
2 mm). Ultrasound imaging for the measurement of cardiac function at day 1 and 14 after surgery, D) fractional shortening, E) LV volume at end-
diastole, F) LV volume at end-systole, G) mitral valve (MV) E/A peak ratio, and H) left ventricular (LV) mass. For MI control (N = 4), MI AuxCP (N = 6) 
and sham (N = 6) hearts (*p < 0.05; Mean ± SE).
www.afm-journal.dewww.advancedsciencenews.com
1800618 (11 of 12) © 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2018, 1800618
krypton fluoride gas (emitting 25 ns pulses of light at 248 nm). The 
light pulses passed through various optics in order to illuminate the 
part of the sample to be ablated, as described previously.[37] The metal 
mask (0.15 mm thick brass) used in this work contained the enlarged 
(by five times) re-entrant honeycomb geometry (12.5 × 12.5 mm2), 
which was then focused on the sample through a 5× projection lens 
(2.5 × 2.5 mm2). The programmable XYZ sample stage moved the 
sample by a precise distance for the ablation to be repeated; hence, 
fabrication of larger patch areas of a repeating pattern was possible. The 
optimum conditions for ablating the chitosan films were identified as 
600 pulses at 350 mJ cm−2 delivered at 40 Hz.
Characterization of Tunable Mechanical Properties—Mechanical 
Characterization: Tensile tests were carried out on patches with 6 × 6 
repeat units in both 1- and 2-directions of the patch (directions 
annotated in Figure 1A). Precise length and width measurements were 
known from the fabrication technique. Thickness was determined by 
scanning electron microscopy, operated at 10 kV (Figure S6, Supporting 
Information, 29.12 ± 6.8 µm, N = 3, n = 5). Patches were wetted with 
deionized water and mounted using custom made stainless steel grips 
on an Electroforce 3200 mechanical tester with a 250 g load cell (TA 
Instruments, New Castle, DE) controlled by WinTest software (Ver. 7). 
Patches were strained to failure at a rate of 0.1% strain s−1, assuming 
quasi-static loading. The effective stiffnesses (E) were determined by 
taking the slope of a regression within the initial linear region of the 
stress–strain curve up to 10% strain. The anisotropic ratio of effective 
stiffnesses (E1/E2) was calculated by dividing the mean of E1 (N = 10) 
by the mean of E2 (N = 10). UTS was measured as the maximum stress 
reached and the strain-at-failure was taken as the strain at the UTS point.
Ex Vivo Investigation of Cardiac Electrophysiology—Myocardial Slice 
Measurements: Live rat left ventricular myocardial slices were prepared 
according to the protocol described by Watson et al.[38] Myocardial slice 
force transducer and microelectrode array measurements were recorded 
as previously described by Mawad et al.[24]
Ex Vivo Investigation of Cardiac Electrophysiology—MI Surgical 
Procedure and Ex Vivo Optical Mapping Experiments: Adult male S-D rats 
(250–350 g) were subjected to MI induced by ligation of the LAD and 
optical mapping was performed as described previously.[24] Data were 
analyzed using a bespoke MATLAB script as described previously.[24,39]
Ex Vivo Investigation of Mechanical Integration: A custom-built device 
was used to cyclically load rat left ventricles with and without an AuxCP 
or UnpatCP attached. The heart was rapidly explanted and rinsed free 
of blood in ice-cold oxygenated Krebs–Henseleit solution (composition 
in mM: 119 NaCl, 4.7 KCl, 0.94 MgSO4, 1 CaCl2, 1.2 KH2PO4, 
25 NaHCO3, 11.5 glucose, and equilibrated with 95% O2 + 5% CO2), 
containing heparin (12 U mL−1) and 30 × 10−3 m 2,3-butanedione 
monoxime (BDM). BDM is a myosin ATPase inhibitor used to inhibit 
contraction and reduce tissue damage during dissection and cyclic 
stretching. The right ventricle was removed, and the septum bisected 
to open the left ventricle. The papillary muscles were cut, and remaining 
septum removed to leave the left ventricular free wall intact and open 
flat. The apical and basal ends of the left ventricular free wall were glued 
via the epicardial surface onto a plastic insert for the biomechanical rig.
The biomechanical rig device consists of a linear actuator which can 
be set to cycle at specific distances, rates, and frequencies. The tissue was 
marked with ink in a grid formation, for image analysis. The tissue 
was cycled ±1 mm under tension at 1 Hz and filmed with a Dino-lite 
Edge AM4815ZT digital microscope (Brunel Microscopes Ltd., 
Wiltshire, UK). The AuxCP or UnpatCP (≈10 × 10 mm) was then secured 
to the epicardium using the laser technology described and shown to be 
safe for tissue applications previously.[24] Briefly, the polyaniline free border 
of the patch (1–2 mm), containing chitosan and Rose Bengal (0.1 w/v%), 
was irradiated by a green diode-pumped solid state laser (532 nm; CNI 
Lasers, China). The laser is set with a power of 170 mW in a continuous 
wave with a beam spot diameter on the tissue of 6 mm. The patch border 
was spot-irradiated for a total time of 4 min. The AuxCPs were always 
oriented so the less stiff 2-direction was aligned with the fibers. The cyclic 
loading was then repeated. Image processing software Fiji (free download 
under https://fiji.sc/) was used to calculate transverse and longitudinal 
strains. The strain values were then normalized to the corresponding 
tissue section before the patch was applied.
In Vivo Investigation of Cardiac Function after Myocardial Infarction—
MI Surgical Procedure and Patch Implantation: Adult male S-D rats 
(250–350 g) were subjected to MI induced by ligation of the LAD, see 
the Supporting Information for further details.
The patches were secured in place using laser technology described 
above.[24] COVA + CARD (Biom’up, France), a cardiac postoperative 
adhesion preventing membrane, was applied to the outside of the 
AuxCP (or on the epicardium in the case of the control groups), and 
sutured in 3–4 places, to the pericardium and thymus.
Statistical Analysis: Mechanical properties and conductivity 
measurements are expressed as mean ± standard deviation (SD). 
In vitro, ex vivo, and in vivo measurements are expressed as mean ± 
standard error of the mean (SE). The nonparametric Mann–Whitney 
post hoc test was used for comparison (OriginPro 9.1, OriginLab 
Corporation). Values of p < 0.05 were considered significant.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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Table S1: Bow-tie dimensions and mechanical properties 
 
 
 
 
 
Set-up No. 1 2 3 4 5 6 7 8 9 
B
o
w
-t
ie
 
d
im
en
si
o
n
s 
A /µm 420 420 420 420 480 420 320 420 420 
B /µm 360 280 240 280 280 240 280 240 280 
A:B 1.17 1.50 1.75 1.50 1.71 1.75 1.14 1.75 1.50 
θ /o 60 60 60 60 60 40 60 80 60 
R /µm 100 100 100 50 100 100 100 100 150 
M
ec
h
a
n
ic
a
l 
P
ro
p
er
ti
es
 
E1 /MPa 1.13 ± 0.2 1.43 ± 0.3 1.39 ± 0.3 0.39 ± 0.2 1.34 ± 0.2 1.01 ± 0.1 2.23 ± 0.2 2.57 ± 0.4 2.77 ± 0.5 
E2 /MPa 0.23 ± 0.1 0.51 ± 0.2 0.78 ± 0.2 0.14 ± 0.04 0.68 ± 0.1 1.19 ± 0.2 0.40 ± 0.1 0.74 ± 0.1 1.10 ± 0.1 
E1/E2 5.0 2.8 1.8 2.7 2.0 0.8 5.6 3.5 2.5 
ν12 -0.87 ± 0.3 -0.47 ± 0.2 -0.32 ± 0.1 -0.51 ± 0.3 -0.21 ± 0.1 -0.45 ± 0.2 -0.32 ± 0.2 0.00 ± 0.00 -0.46 ± 0.3 
ν21 -0.34 ± 0.1 -0.43 ± 0.3 -0.50 ± 0.2 -0.38 ± 0.2 -0.84 ± 0.4 -1.45 ± 0.2 -0.18 ± 0.1 0.08 ± 0.1 -0.84 ± 0.3 
UTS1 /MPa 1.58 ± 0.9 1.15 ± 0.6 1.12 ± 0.6 0.06 ± 0.03 0.42 ± 0.2 1.12 ± 0.5 0.70 ± 0.4 0.24 ± 0.2 1.49 ± 0.6 
UTS2 /MPa 0.60 ± 0.3 0.72 ± 0.4 1.46 ± 0.5 0.11 ± 0.03 0.73 ± 0.2 1.17 ± 0.6 0.76 ± 0.4 0.61 ± 0.4 0.70 ± 0.2 
ε1 /% 47 ± 25 27 ± 6 34 ± 10 27 ± 12 34 ± 12 55 ± 7 49 ± 23 36 ± 22 40 ± 8 
ε2 /% 55 ± 25 37 ± 8 28 ± 4 50 ± 26 44 ± 10 50 ± 15 96 ± 29 40 ± 12 48 ± 14 
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Figure S1 A and B) Digital optical microscope images of the AuxCPs during tensile testing 
at A) 0.8 % strain and B) 12.6 % strain (scale bars: 1 mm), including annotation to indicate 
the measurements taken to calculate the Poisson’s ratio. C) Representative graph of Poisson’s 
ratio (in each direction; ν12 and ν21) against strain. 
 
Figure S2 A and B) Optical microscope images of the AuxCPs created by excimer laser 
microablation A) before and B) after coating with polyaniline and phytic acid (scale bars: 
200 µm).  
  
4 
 
 
 
Figure S3: A-C) Three separate sets of representative stress-strain curves for an auxetic 
cardiac patch (AuxCP, set-up 2) in both the 1 and 2-directions, showing i) the whole tensile 
test and ii) the first 10 % strain only. 
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Figure S4: A and B) Confocal microscopy images of neonatal rat ventricular myocytes and 
fibroblasts cultured on the auxetic cardiac patches (AuxCPs) for 3 days, fluorescently stained 
for vimentin (green), α-actinin (red) and nuclei (blue), (scale bar: 50 µm.) C) Cell metabolic 
activity determined by an MTS assay of neonatal rat ventricular myocytes and fibroblasts 
cultured on glass controls, unpatterned cardiac patches (UnpatCPs) and AuxCPs after 3 days 
in culture, (N = 6, *p < 0.05; Mean ± SE.) 
 
Table S2: List of bow-tie dimensions and mechanical properties for AuxCP-10, discussed in 
section 2.5.2. 
 
Bow-Tie Dimensions Mechanical Properties 
A /µm B /µm A:B θ /o R /µm E1 /MPa E2 /MPa E1/E2 
425 245 1.73 36 100 2.16 ± 0.2 1.33 ± 0.1 1.63 ± 0.2 
 
 
 
Figure S5: Optical mapping measurements on whole hearts with AuxCP-10 attached. A) 
Conduction velocity (CV) in healthy and MI hearts, (N = 10, *p < 0.05; Mean ± SE). CV in 
B) healthy hearts and C) MI hearts after patch application, normalized to the hearts without 
the patch, (N = 4-5; Mean ± SE). 
 
  
6 
 
 
Figure S6: Representative scanning electron microscopy (SEM) images of 3 different 
samples of the chitosan-polyaniline thin film patches (UnpatCPs) to illustrate how the film 
thickness was calculated. Film thickness = 29.12 ± 6.8 µm. (scale bar = 50 µm; N = 3, n = 5, 
Mean ± SD). 
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Extended Experimental Section  
Characterization of the Poisson’s Ratio 
The Poisson’s ratio (ν) is the negative ratio of the transverse strain (εT) to longitudinal 
strain (εL). Poisson’s ratio measurements were calculated from Dino-lite Edge AM4815ZT 
digital microscope videos (Brunel Microscopes Ltd, Wiltshire, UK) of the tensile tests. The 
images were processed using a method similar to that previously described by Clausen et 
al.
[17]
 The MATLAB Image Processing Toolbox was used to convert the videos into still 
images and then contour plots. Image processing software Fiji was used to measure all 
distances in pixels across the length and width of the central 2 x 2 repeat units to calculate the 
transverse (εT) and longitudinal strain (εL) for all images and therefore determine the 
Poisson’s ratio, (     
  
  
). Characterization of Conductivity 
The electrodes were gold-coated Mylar (VacuLayer Corp) held in place on the 
conductive side of the patch and connected to an eDAQ EA163 potentiostat. The I-V 
characteristics of the films were recorded by sweeping the voltage between ± 1 V at 100 
mV·s
-1
. The resistivity (ρ) was calculated according to Equation (S1): 
  
 
 
    (S1) 
where R is the resistance of the film calculated from the slope of the V vs I plot, A is the cross-
sectional area of the film (0.15 mm) and L is the distance between the two electrodes (5 mm). 
The conductivity (σ) could then be calculated from Equation (S2): 
  
 
 
    (S2) 
Neonatal Rat Ventricular Myocytes Cultured on Auxetic Cardiac Patches 
Cell culture: Chamber slides were coated with 1.5 w/v% sterile agarose to block cell 
adhesion to the bottom of the slide. Patches were placed in each well and held in place by 
sterile silicone o-rings (Polymax Ltd, UK). The patches were then sterilized with UV for 30 
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minutes and incubated with sterile water followed by FBS for 48 hours each, prior to cell 
seeding.  
Neonatal rat ventricular myocytes (NRVMs) were isolated from Sprague-Dawley (S-
D) rats 0-2 days after birth by excising the hearts and isolating the ventricles. A GentleMACs 
neonatal heart dissociation kit (Miltenyi Biotec) was used to enzymatically digest the 
ventricles to produce a cell suspension containing NRVMs and fibroblasts. Each patch was 
seeded with 200,000 NRVMs and fibroblasts in NRVM medium. All experiments were 
conducted at 2-3 days post seeding unless stated otherwise.  
MTS assay: Cell metabolic activity was also assessed by quantification of the 
reduction of MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) (Promega) to a colored formazan product, and the absorbance 
was read on a Promega Glomax multi detection system at 490 nm.  
Immunofluorescence staining: NRVMs and fibroblasts were stained for α-actinin and 
vimentin, respectively, with the following antibodies: mouse anti- α-actinin primary antibody 
(diluted 1:1000), followed by goat anti-mouse Cy3 secondary antibody (1:1000) (Millipore) 
and rabbit anti-vimentin primary antibody (1:1000), followed by donkey anti-rabbit Alexa 
488 secondary antibody (1:1500), before mounting in Vectashield (Vectalabs) mounting 
medium containing DAPI. The cells were imaged using an inverted Zeiss LSM-780 confocal 
microscope. Image processing software Fiji was used for all image analysis. 
In vivo investigation of cardiac function after myocardial infarction  
Animal Preparation:  Animals were ordered from Charles River Laboratories and left 
to acclimatize for at least 1 week before the surgery was performed. Anesthesia was induced 
with 5 % isoflurane (Zoatis, UK) and surgical anesthesia was confirmed by the loss of 
standing and pedal reflexes. The hairs were removed from the left part of the thorax using 
clippers (Harvard Apparatus, UK) and the eyes were hydrated with Lacri-lube® (Allergan, 
UK). Buprenorphine (0.05 mg/kg, Vetergesic®, Ceva, UK) diluted in saline was administered 
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subcutaneously for analgesia and fluid therapy. Rats were intubated with an appropriate 
cannula (Williams Medical Supplies, UK) and mechanically ventilated (Harvard Apparatus, 
UK). Ventilation parameters were adjusted based on the animal weight and chest movement. 
Body temperature was maintained during the whole procedure using an adjustable heating 
mat. The surgical site was then scrubbed using diluted iodine solution and isoflurane was then 
reduced and maintained at 2 % during the whole procedure.   
MI, Patch Implantation and Aftercare:  The heart was exposed by a horizontal incision 
of the skin followed by the dissociation of the thorax and intercostal muscles to access the 
base of the left ventricle. The pericardium was ruptured, and the MI was induced by ligation 
of the left anterior descending coronary artery (LAD), ligated 1-2mm distal to the inferior 
border of the left atrium using a 7/0 Prolene suture. Effective ligation was confirmed by 
blanching and cyanosis of the left ventricular free wall and apex. The patch was secured in 
place as described earlier. 
The rib cage and muscles were then closed with a resorbable 4/0 suture (PDS™II, 
Ethicon, Belgium). The anesthesia was turned down to 1 % isoflurane and the skin was closed 
with the same suture. At the end of the surgery, the anesthetic gas was turned off and the 
animal was extubated and placed in a heat chamber until full recovery. Animals were checked 
regularly for signs of pain/distress and analgesia was maintained for 1 day using 
Buprenorphine (0.05 mg/kg, Vetergesic, Ceva, UK). 
Heart Isolation:  At the end of the experiment, the hearts were isolated under non-
recovery anesthesia. Briefly, the chest of the animal was opened to expose the heart. A 
solution of potassium chloride (50 mM in DI-H2O) was injected in the left ventricle through 
the apex to stop the heart in diastole, followed by a solution of 3.7 % PFA to fix the tissue in 
situ. The heart was then removed, placed in 3.7 % PFA for 24 hours at room temperature, and 
was then transferred to 70 % ethanol before preparation for histology.  
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Ultrasound Imaging for the Measurement of Systolic and Diastolic Function:  
Ultrasound measurements were performed on a Vevo 2100 system (VisualSonics, California, 
CA, USA) using an MS550D 30 MHz transducer (VisualSonics). Rats were anaesthetized 
with 1.5–2.0 % isoflurane in 2 L·min-1 oxygen and positioned supine on a physiological 
monitoring platform which simultaneously regulated body temperature, whilst measuring 
respiration and ECG traces. Prior to imaging, hair was removed from the chest to reduce the 
attenuation of the ultrasound signal. 
For the assessment of systolic function, parasternal long axis m-mode images were 
acquired and volumes were calculated using Teichholz's formula.
[S1]
 For the assessment of 
diastolic function, we used color B mode guided, pulsed wave, Doppler mode ultrasound to 
measure mitral inflow in an apical four chamber view of the heart. E and A peaks were 
measured from three consecutive heart beats, and the mean E/A ratio was calculated for each 
animal.
[S2]
 LV mass was calculated from short axis m-mode images using the standard 
formula as follows: 
                                          
Where LVIDd is the left ventricular internal dimension at diastole, PWDd is the 
posterior wall dimension at diastole, AWDd is the anterior wall dimension at diastole and 
1.05 is the specific gravity of the myocardium. 
Histology and Immunohistochemistry:  Histology and immunohistochemistry were 
carried out as previously described.
[40]
 Briefly, the isolated hearts were cut into 2 mm thick 
cross-sections and embedded in paraffin wax. The tissue-paraffin blocks were cut into thin 
sections (5 µm) using a microtome and mounted onto glass slides. The slides were then 
stained with either PicroSirius Red or hematoxylin and eosin (H and E). The samples were 
examined with a wide field microscope. Image processing software Fiji (ImageJ) was used for 
all image analysis.  
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